Treatment method
A treatment method is disclosed capable of reducing the burden on a patient and enhancing the effect of killing tumor cells. A treatment method for killing a tumor cell, the method including inserting a catheter into a main artery of an organ having the tumor cell, administering an antibody-photosensitive substance into a vein before the inserting of the catheter, inserting an optical fiber into the catheter, reducing an influence of blood in the artery on a near-infrared ray, irradiating at least one of a tumor, the vicinity of the tumor, or a regional lymph node with a first near-infrared ray by the optical fiber, and irradiating an antibody-photosensitive substance bound to a tumor cell membrane in the tumor cell with a second near-infrared ray having a shorter wavelength than that of the first near-infrared ray.
1. A treatment method for killing a tumor cell, the method comprising:
administering an antibody-photosensitive substance into a vein;
puncturing a tumor having the tumor cell or a vicinity of the tumor percutaneously with a hollow needle while acquiring and checking an ultrasound image percutaneously after the administering of the antibody-photosensitive substance into the vein;
bringing an optical fiber inserted into a lumen of the needle into the tumor or the vicinity of the tumor;
irradiating at least one of the tumor, the vicinity of the tumor, or a regional lymph node with a first near-infrared ray by the optical fiber; and
irradiating the antibody-photosensitive substance bound to a tumor cell membrane in the tumor cell with a second near-infrared ray after the irradiating of the at least one of the tumor, the vicinity of the tumor, or the regional lymph node with the first near-infrared ray, the second near-infrared ray having a shorter wavelength than that of the first near-infrared ray.
2. The treatment method according to claim 1 , wherein, in the irradiating with the first near-infrared ray and/or the irradiating with the second near-infrared ray, the needle has a light-transmitting portion capable of transmitting a near-infrared ray at a distal portion, and wherein the method further comprises:
emitting one or more of the first near-infrared ray and the second near-infrared ray from the optical fiber located inside the needle through the light-transmitting portion.
3. The treatment method according to claim 1 , wherein, in the irradiating with the first near-infrared ray and/or the irradiating with the second near-infrared ray, the needle has a slit through which a near-infrared ray is emitted at a distal portion, and wherein the method further comprises:
emitting one or more of the first near-infrared ray and the second near-infrared ray from the optical fiber located inside the needle through the slit.
4. The treatment method according to claim 1 , wherein the treatment method is for treating breast cancer, liver cancer, skin cancer, and/or head and neck cancer.
5. The treatment method according to claim 1 , comprising:
emitting the first near-infrared ray at a wavelength of about 1064 nm; and
emitting the second near-infrared ray at a wavelength of 660 nm to 740 nm with a dose of 1 Jcm −2 to 50 Jcm −2 .
6. The treatment method according to claim 1 , further comprising:
monitoring the tumor cell to which the antibody-photosensitive substance is bound while being irradiated with the second near-infrared ray with a temperature measurement device and/or a hardness measurement device to detect change in temperature and/or hardness of the tumor.
7. The treatment method according to claim 6 , wherein the hardness measurement device transmits ultrasound waves, which are detected by an ultrasound probe, the treatment method comprising:
calculating a tomographic image of the tumor; and detecting a change in a hardness of the tumor based on a change in a luminance of the tomographic image.
8. The treatment method according to claim 1 , further comprising:
starting the irradiation with the first near-infrared ray, 12 hours to 36 hours after the administering of the antibody-photosensitive substance into the vein; and
starting the irradiation with the second near-infrared ray, 12 hours to 36 hours after the administering of the antibody-photosensitive substance into the vein.
9. The treatment method according to claim 1 , wherein the antibody-photosensitive substance comprises:
binding an antibody that specifically binds only to a specific antigen on a surface of the tumor cell and a photosensitive substance that is paired with the antibody.
10. The treatment method according to claim 9 , wherein the antibody is panitumumab, trastuzumab, or HuJ591, and the photosensitive substance is hydrophilic phthalocyanine.
11. The treatment method according to claim 1 , wherein the needle is an outer needle, and an inner needle is accommodated within the outer needle, the inner needle including a plurality of elastically deformable branch needles, and wherein the optical fiber comprises a plurality of optical fibers corresponding to a number of the plurality of elastically deformable branch needles, and wherein each of the elastically deformable branch needles is configured to receive one of the plurality of optical fibers, the method further comprising:
protruding the plurality of elastically deformable branch needles of the inner needle from the outer needle towards a distal side of the needle and spreading the plurality of elastically deformable branch needles into the tumor or the vicinity of the tumor; and
inserting the plurality of optical fibers into each of the plurality of elastically deformable branch needles such that an irradiation unit of each of the plurality of optical fibers protrudes from the plurality of elastically deformable branch needles.
12. A treatment method for killing a tumor cell, the method comprising:
puncturing a tumor having the tumor cell or a vicinity of the tumor percutaneously with a hollow needle while acquiring and checking an ultrasound image percutaneously;
administering an antibody-photosensitive substance into the tumor or the vicinity of the tumor from the needle after the bringing of the needle to the vicinity of the tumor;
bringing an optical fiber inserted into a lumen of the needle into the tumor or the vicinity of the tumor;
irradiating at least one of the tumor, the vicinity of the tumor, or a regional lymph node with a first near-infrared ray by the optical fiber; and
irradiating the antibody-photosensitive substance bound to a tumor cell membrane in the tumor cell with a second near-infrared ray after the irradiating of the at least one of the tumor, the vicinity of the tumor, or the regional lymph node with the first near-infrared ray, and wherein the second near-infrared ray has a shorter wavelength than that of the first near-infrared ray.
13. The treatment method according to claim 12 , wherein, in the irradiating with the first near-infrared ray and/or the irradiating with the second near-infrared ray, the needle has a light-transmitting portion capable of transmitting a near-infrared ray at a distal portion, and wherein the method further comprises:
emitting one or more of the first near-infrared ray and the second near-infrared ray from the optical fiber located inside the needle through the light-transmitting portion.
14. The treatment method according to claim 12 , wherein, in the irradiating with the first near-infrared ray and/or the irradiating with the second near-infrared ray, the needle has a slit through which a near-infrared ray is emitted at a distal portion, and wherein the method further comprises:
emitting one or more of the first near-infrared ray and the second near-infrared ray from the optical fiber located inside the needle through the slit.
15. The treatment method according to claim 12 , comprising:
emitting the first near-infrared ray at a wavelength of about 1064 nm; and
emitting the second near-infrared ray at a wavelength of 660 nm to 740 nm with a dose of 1 Jcm −2 to 50 Jcm −2 .
16. The treatment method according to claim 12 , further comprising:
monitoring the tumor cell to which the antibody-photosensitive substance is bound while being irradiated with the second near-infrared ray with a temperature measurement device and/or a hardness measurement device to detect change in temperature and/or hardness of the tumor.
17. The treatment method according to claim 16 , wherein the hardness measurement device transmits ultrasound waves, which are detected by an ultrasound probe, the treatment method comprising:
calculating a tomographic image of the tumor; and detecting a change in a hardness of the tumor based on a change in a luminance of the tomographic image.
18. The treatment method according to claim 12 , wherein the antibody-photosensitive substance comprises:
binding an antibody that specifically binds only to a specific antigen on a surface of the tumor cell and a photosensitive substance that is paired with the antibody.